AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 41 min read$KIDS

Pelizzon David R sold $525K of KIDS (indirect holdings)

Pelizzon David R sold 22,500 indirectly-held shares of ORTHOPEDIATRICS CORP (KIDS) at $23.35 ($0.53M total) on 2026-09-02.

Original reporting
SEC EDGAR · Pelizzon David R
Published Sep 4, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 8:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishLow
01

Why it matters

The sale provides fresh data on insider sentiment, useful for short‑term traders.

02

Market read

New insider transaction; modest relevance for traders monitoring KIDS.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 5/10Novelty 4/10Timing: post‑market 2026‑09‑02

Background

Form 4 filing discloses a director's open‑market sale of KIDS shares.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

Director Pelizzon sold 22,500 shares for $525,375, reducing his stake.

Expected impact

Potential short-term dip of 1-2% as market digests the sale.

Evidence & confidence

Sale size is modest relative to float, but director ownership is sizable; market may react cautiously.

Market effects

Sector

Minimal impact on orthopedics sector; similar insider sales have limited sector ripple.

Regional

US market only; no broader regional effect.

Global

Low global relevance.

Counterpoint

What could challenge this read

Insider may be diversifying; sale does not necessarily indicate negative outlook.

Key entities

  • Company
    Orthopedics Corp.

    Issuer of KIDS ticker.

  • Insider
    Pelizzon David R.

    Director and 10% owner of Orthopedics Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

KIDS insider trading history →

Related articles

SEP 11
$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

insidermonkey.com2 min
AUG 6
$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.

yahoo.com7 min